Michiels, Y.; Houhou-Fidouh, N.; Collin, G.; Berger, J.; Kohli, E.
Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis. Vaccines 2021, 9, 883.
https://doi.org/10.3390/vaccines9080883
AMA Style
Michiels Y, Houhou-Fidouh N, Collin G, Berger J, Kohli E.
Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis. Vaccines. 2021; 9(8):883.
https://doi.org/10.3390/vaccines9080883
Chicago/Turabian Style
Michiels, Yves, Nadhira Houhou-Fidouh, Gilles Collin, Jérôme Berger, and Evelyne Kohli.
2021. "Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis" Vaccines 9, no. 8: 883.
https://doi.org/10.3390/vaccines9080883
APA Style
Michiels, Y., Houhou-Fidouh, N., Collin, G., Berger, J., & Kohli, E.
(2021). Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis. Vaccines, 9(8), 883.
https://doi.org/10.3390/vaccines9080883